We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Appeals Court Upholds Ruling Favoring Transkaryotic in Patent Suit

Law360 (October 12, 2003, 12:00 AM EDT) -- An appeals court upheld a ruling that Transkaryotic Therapies Inc. didn't infringe on patents related to its Fabry disease treatment, Dow Jones Newswires reported.

Only a day earlier, Genzyme Corp. pulled out of the litigation as part of a settlement. Genzyme and Mount Sinai School of Medicine claimed that Transkaryotic's main product, Replagal, infringed on one of their patents.

A Delaware district court dismissed the lawsuit in January 2002, and Genzyme and Mount Sinai appealed the decision in March of that year.

As part of the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.